3NV-27262-90995
2 vaccinations
1 coded response
21 check-ins
0 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 939 / CA
- Registered
- 2023-04-01
- Relationship
- Child or adolescent in my care
- Guardian
- XGF-64012-27231
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2023-04-01
Registered in v-safe
-
2023-04-01
Dose 1 — Pfizer-BioNTech
- 2023-04-01
- 2023-04-02
- 2023-04-03
- 2023-04-04
- 2023-04-05
- 2023-04-07
- 2023-04-08
- 2023-04-17
-
2023-04-22
Survey response — day 21, dose 1, under 3MedDRA: Viral upper respiratory tract infection — Feeling: GoodMedDRA releases: 2024-11
- 2023-04-29
-
2023-05-06
Dose 2 — Pfizer-BioNTech
- 2023-05-06
- 2023-05-07
- 2023-05-10
- 2023-05-11
- 2023-05-12
- 2023-05-15
- 2023-05-20
- 2023-05-27
- 2023-06-03
- 2023-06-10
- 2023-06-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2023-04-01 | Pfizer-BioNTech | No |
| 2 | 2023-05-06 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Viral upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release